Challenges in the treatment of cardioembolic stroke

When is it the right time to start the right treatment for patients with cardioembolic stroke? In this video, Dr Valeria Caso answers this critical question.

Dr. Caso has disclosed that he was/is on the speakers bureau for Biogen; was/is a consultant/advisor and grant/research support recipient for Boehringer Ingelheim, Daiichi-Sankyo, Pfizer-BMS, Bayer